Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension | MicrobiomeTrials← Back to trialsNCT06205628
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-03-21Est. Completion: 2026-07-31
Enrollment target: 28 participants Locations- CMAX Clinical Research, Adelaide, South Australia, Australia
- Linear Clinical Research, Nedlands, Western Australia, Australia
- Clinitrials Pty Ltd, Perth, Australia
Other microbiome trials you might be interested in
Pediatric HypertensionPrimary HypertensionEndothelial Dysfunction
Childhood hypertension is associated with early endothelial dysfunction and an increased risk of future cardiovascular d…
Osijek, CroatiaEst. completion Apr 30, 2029
Chronic Kidney Disease
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a…
Huntsville, United StatesEst. completion Aug 20, 2026